| Clinical development is undergoing a structural shift. Protocols are growing more complex, budgets are shrinking, and ...

Thermo Fisher Scientific Inc., a leading U.S.-based medical equipment manufacturer, is reportedly close to finalizing an ...

Every year, millions of dollars are lost to delays and inefficiencies in utilization management, making it one of the most daunting obstacles impeding timely, a ...

Thermo Fisher said on Wednesday it would buy privately held data management company Clario for up to $9.4 billion, ...

Vibhor Gupta, PhD, founder & CEO of patient data AI platform Pangaea Data, highlights a widespread failure to extract value ...

AI promises to revolutionize healthcare, but integration is far from simple, so let's look at the real-world barriers, ...

Mast cell tumors are prevalent skin neoplasms observed in veterinary clinical practice, particularly affecting both dogs and cats. Over the years, rigorous ...

Artificial intelligence (AI) is rapidly transforming clinical trials by dramatically reducing timelines and costs, accelerating patient-centered drug development and creating more resilient and ...

ICH gives CGT developers a regulatory framework that finally matches the speed and flexibility their groundbreaking therapies ...

PhiliaHealth is a company founded on the belief that stress should be measured, understood, and addressed with the same precision as any other biological process.

Sean Virani, MD, lead author of the new guidelines and president of the CCS, explained that the guidelines use the term ...